
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5373658
[patent_doc_number] => 20090311219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Oncolytic Adenoviruses for Cancer Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/184881
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12814
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311219.pdf
[firstpage_image] =>[orig_patent_app_number] => 12184881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/184881 | Oncolytic Adenoviruses for Cancer Treatment | Jul 31, 2008 | Abandoned |
Array
(
[id] => 6234847
[patent_doc_number] => 20100266551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN'
[patent_app_type] => utility
[patent_app_number] => 12/670451
[patent_app_country] => US
[patent_app_date] => 2008-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6220
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266551.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670451
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670451 | ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN | Jul 24, 2008 | Abandoned |
Array
(
[id] => 5558908
[patent_doc_number] => 20090270485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site'
[patent_app_type] => utility
[patent_app_number] => 12/220686
[patent_app_country] => US
[patent_app_date] => 2008-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 22241
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270485.pdf
[firstpage_image] =>[orig_patent_app_number] => 12220686
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/220686 | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site | Jul 23, 2008 | Abandoned |
Array
(
[id] => 6328362
[patent_doc_number] => 20100197767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'NUCLEIC ACID CONSTRUCT SYSTEMS CAPABLE OF DAIGNOSING OR TREATING A CELL STATE'
[patent_app_type] => utility
[patent_app_number] => 12/452573
[patent_app_country] => US
[patent_app_date] => 2008-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15003
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197767.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452573 | NUCLEIC ACID CONSTRUCT SYSTEMS CAPABLE OF DAIGNOSING OR TREATING A CELL STATE | Jul 9, 2008 | Abandoned |
Array
(
[id] => 6575264
[patent_doc_number] => 20100129399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/666459
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6441
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129399.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666459
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666459 | LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF INFLUENZA VIRUS PARTICLES | Jun 25, 2008 | Abandoned |
Array
(
[id] => 5271594
[patent_doc_number] => 20090075370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Vectors'
[patent_app_type] => utility
[patent_app_number] => 12/139035
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15456
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075370.pdf
[firstpage_image] =>[orig_patent_app_number] => 12139035
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/139035 | Vectors | Jun 12, 2008 | Abandoned |
Array
(
[id] => 5349303
[patent_doc_number] => 20090004664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'HCV NS3 replicon shuttle vectors'
[patent_app_type] => utility
[patent_app_number] => 12/156871
[patent_app_country] => US
[patent_app_date] => 2008-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6318
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004664.pdf
[firstpage_image] =>[orig_patent_app_number] => 12156871
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/156871 | HCV NS3 replicon shuttle vectors | Jun 4, 2008 | Abandoned |
Array
(
[id] => 4759951
[patent_doc_number] => 20080312177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/132533
[patent_app_country] => US
[patent_app_date] => 2008-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 23737
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312177.pdf
[firstpage_image] =>[orig_patent_app_number] => 12132533
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/132533 | SERCA2 THERAPEUTIC COMPOSITIONS AND METHODS OF USE | Jun 2, 2008 | Abandoned |
Array
(
[id] => 5416410
[patent_doc_number] => 20090042297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Piggybac transposon-based vectors and methods of nucleic acid integration'
[patent_app_type] => utility
[patent_app_number] => 12/156531
[patent_app_country] => US
[patent_app_date] => 2008-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 35698
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042297.pdf
[firstpage_image] =>[orig_patent_app_number] => 12156531
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/156531 | Piggybac transposon-based vectors and methods of nucleic acid integration | Jun 1, 2008 | Abandoned |
Array
(
[id] => 4758869
[patent_doc_number] => 20080311095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Methods and compositions for increased transgene expression'
[patent_app_type] => utility
[patent_app_number] => 12/154439
[patent_app_country] => US
[patent_app_date] => 2008-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14959
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20080311095.pdf
[firstpage_image] =>[orig_patent_app_number] => 12154439
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/154439 | Methods and compositions for increased transgene expression | May 21, 2008 | Abandoned |
Array
(
[id] => 5569385
[patent_doc_number] => 20090252763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'BIOLOGICAL ADJUVANTS'
[patent_app_type] => utility
[patent_app_number] => 12/121119
[patent_app_country] => US
[patent_app_date] => 2008-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1526
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20090252763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12121119
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/121119 | BIOLOGICAL ADJUVANTS | May 14, 2008 | Abandoned |
Array
(
[id] => 5446009
[patent_doc_number] => 20090047235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Paratransgenesis to Control Termites or Other Social Insects'
[patent_app_type] => utility
[patent_app_number] => 12/120717
[patent_app_country] => US
[patent_app_date] => 2008-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7268
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047235.pdf
[firstpage_image] =>[orig_patent_app_number] => 12120717
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/120717 | Paratransgenesis to Control Termites or Other Social Insects | May 14, 2008 | Abandoned |
Array
(
[id] => 6262323
[patent_doc_number] => 20100297085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'Synthetic Herpes Simplex Viruses Type-1 for Treatment of Cancers'
[patent_app_type] => utility
[patent_app_number] => 12/598937
[patent_app_country] => US
[patent_app_date] => 2008-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16775
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12598937
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598937 | Synthetic herpes simplex viruses type-1 for treatment of cancers | May 8, 2008 | Issued |
Array
(
[id] => 9047012
[patent_doc_number] => 08541566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Promoter inducible by reactive oxygen species and vector comprising the same'
[patent_app_type] => utility
[patent_app_number] => 12/597891
[patent_app_country] => US
[patent_app_date] => 2008-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 23
[patent_no_of_words] => 9075
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12597891
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/597891 | Promoter inducible by reactive oxygen species and vector comprising the same | Apr 24, 2008 | Issued |
Array
(
[id] => 6149330
[patent_doc_number] => 20110020925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'NEW MODULATING MOLECULES FOR AN IMPROVED REGULATED EXPRESSION SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/594941
[patent_app_country] => US
[patent_app_date] => 2008-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 70898
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020925.pdf
[firstpage_image] =>[orig_patent_app_number] => 12594941
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/594941 | NEW MODULATING MOLECULES FOR AN IMPROVED REGULATED EXPRESSION SYSTEM | Apr 10, 2008 | Abandoned |
Array
(
[id] => 4682253
[patent_doc_number] => 20080248479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods for Isolating and Characterizing Endogenous mRNA-Protein (mRNP) Complexes'
[patent_app_type] => utility
[patent_app_number] => 12/049862
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13923
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248479.pdf
[firstpage_image] =>[orig_patent_app_number] => 12049862
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/049862 | Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes | Mar 16, 2008 | Issued |
Array
(
[id] => 4663621
[patent_doc_number] => 20080254528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Baculovirus Expression System'
[patent_app_type] => utility
[patent_app_number] => 12/047469
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13211
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254528.pdf
[firstpage_image] =>[orig_patent_app_number] => 12047469
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/047469 | Baculovirus expression system | Mar 12, 2008 | Issued |
Array
(
[id] => 5360553
[patent_doc_number] => 20090035347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/043903
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16024
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20090035347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12043903
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/043903 | ISOLATED STROMAL CELLS AND METHODS OF USING THE SAME | Mar 5, 2008 | Abandoned |
Array
(
[id] => 10090268
[patent_doc_number] => 09127082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'MANF2 for treatment of Parkinson\'s disease'
[patent_app_type] => utility
[patent_app_number] => 12/037535
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25997
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12037535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037535 | MANF2 for treatment of Parkinson's disease | Feb 25, 2008 | Issued |
Array
(
[id] => 6530206
[patent_doc_number] => 20100221225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/305869
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 20511
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221225.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305869 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASES | Feb 24, 2008 | Abandoned |